Effects of COVID-19 Outbreak on Emergency Surgeries for Occlusive Colorectal Cancers

Ferahman, Sina; Dönmez, Turgut; Sürek, Ahmet; Aydın, Hüsnü; Gumusoglu, Alpen Yahya; Karabulut, Mehmet

doi:10.4274/tjcd.galenos.2020.2020-7-2

Cited by 8 publications

(36 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Fourteen indicators from 7 articles [41,47,57,69,97,100,105] evaluated the “clinical severity at diagnosis”, which included symptoms, scores, and biomarkers. The majority (n=8 indicators, 57%) showed patients presenting in a more severe clinical condition than before the pandemic, namely in US (endometrial cancer), Portugal (hepatocellular carcinoma), Italy, and Turkey (colorectal cancer).…”

Section: Resultsmentioning

confidence: 99%

“…Two main outcomes were addressed in the included articles: "procedures and surgical outcome measures" and "mortality". Fifteen indicators from 8 articles [93,[97][98][99][100][101][102][103] conveyed information regarding procedures' outcomes. From these indicators, 11 (73%) showed similar complication rates.…”

Section: Discussionmentioning

confidence: 99%

“…Twenty of these indicators resulted from one Portuguese study [105], the other 3 indicators showed a stable postoperative death rate in patients with head and neck cancer (France) [102], and a stable in-hospital mortality rate for orthopedic tumors at the traumatology department (Germany) [123]. One Turkish study [100] documented increased mortality in occlusive colorectal cancers patients.…”

Section: Discussionmentioning

confidence: 99%

“…With respect to the proportion of earliest stage cancers, most of the indicators (n=9, 63%) showed a lower proportion of these cancers when compared with pre-pandemic period, 9 (26%) signalled a stable trend, and 4 (11%) showed an increasing trend. From the indicators reporting on the proportion of advanced-stage cancers, 43 (70%) showed an increasing trend in this proportion after the beginning of the pandemic, 14 (23%) signalled a stable proportion, and 4 (7%) reported a decreasing trend.Fourteen indicators from 7 articles[41,47,57,69,97,100,105] evaluated the "clinical severity at diagnosis", which included symptoms, scores, and biomarkers. The majority (n=8 indicators, 57%)…”

mentioning

confidence: 99%

“…The indicators that reported on "changes in cancer staging" were grouped in 3 different categories: general staging indicators (14 indicators from 8 articles[75,77,81,[94][95][96][97][98]), proportion of earliest-stage cancers (35 indicators from 9 articles[41,71,81,[99][100][101][102][103][104]), and proportion of advanced-stage cancers (61 indicators from 17 articles[39,57,63,66,77,79,87,92,93,[95][96][97][98][99][100][101][102]). Most of the general staging indicators (n=9, 64%) showed stability in cancer stages distribution at diagnosis, when comparing the pre-and post-lockdown periods (data from Italy, US, UK, France, US, and Portugal).…”

mentioning

confidence: 99%

See 4 more Smart Citations

Changes in the quality of cancer care as assessed through performance indicators during the first wave of the COVID-19 pandemic in 2020: a Scoping Review

Carvalho

Fernandes

Lange

et al. 2022

Preprint

View full text Add to dashboard Cite

Objectives: Summarize performance indicators used in the literature to evaluate the impact of the COVID-19 pandemic on cancer care (January-June 2020), and to assess changes in the quality of care as assessed via selected indicators. Methods: Scoping review. Indicators and their reported trends were collated following the cancer care pathway. Results: Database searches retrieved 6277 articles, 838 articles met the inclusion criteria, and 135 articles were included after full-text screening, from which 917 indicators were retrieved. Indicators assessing the diagnostic process showed a decreasing trend: from 33 indicators reporting on screening, 30 (91%) signalled a decrease during the pandemic (n=30 indicators, 91%). A reduction was also observed in the number of diagnostic procedures (n=64, 58%) and in the diagnoses (n=130, 89%). The proportion of diagnoses in the emergency setting and waiting times showed an increasing trend (n=8, 89% and n=14, 56%, respectively). Nine indicators (64%) showed stability in cancer stages distribution. A decreasing trend in the proportion of earliest stage cancers was reported by 63% of indicators (n=9), and 70% (n=43) of indicators showed an increasing trend in the proportion of advanced-stage cancers. Indicators reflecting the treatment process signalled a reduction in the number of procedures: 79% (n=82) of indicators concerning surgeries, 72% (n=41) of indicators assessing trends in radiotherapy, and 93% (n=40) of indicators related to systemic therapies. Modifications in cancer treatment were frequently reported: 64% (n=195) of indicators revealed changes in treatment. Ten indicators (83%) signalled a decreasing number of hospital admissions. Conclusion: Health systems struggled to ensure continuity of cancer care. As this pandemic keeps evolving, the trends reported over the first 6 months of 2020 provide an argument to monitor these changes closely. This information needs to be transparent, standardised, and timely, allowing to monitor quality and outcomes of care during crises and inform policy responses.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

mentioning

confidence: 99%

mentioning

confidence: 99%

See 3 more Smart Citations

Changes in the quality of cancer care as assessed through performance indicators during the first wave of the COVID-19 pandemic in 2020: a Scoping Review

Carvalho

Fernandes

Lange

et al. 2022

Preprint

View full text Add to dashboard Cite

show abstract

The safety of digestive tract cancer surgery during COVID-19: A living systematic review and meta-analysis

Wang

Yao

et al. 2023

Asian Journal of Surgery

View full text Add to dashboard Cite

Changes in the quality of cancer care as assessed through performance indicators during the first wave of the COVID-19 pandemic in 2020: a scoping review

Carvalho

Fernandes

Lange

et al. 2022

BMC Health Serv Res

View full text Add to dashboard Cite

Background Cancer comprises a high burden on health systems. Performance indicators monitoring cancer outcomes are routinely used in OECD countries. However, the development of process and cancer-pathway based information is essential to guide health care delivery, allowing for better monitoring of changes in the quality of care provided. Assessing the changes in the quality of cancer care during the COVID-19 pandemic requires a structured approach considering the high volume of publications. This study aims to summarize performance indicators used in the literature to evaluate the impact of the COVID-19 pandemic on cancer care (January-June 2020) in OECD countries and to assess changes in the quality of care as reported via selected indicators. Methods Search conducted in MEDLINE and Embase databases. Performance indicators and their trends were collated according to the cancer care pathway. Results This study included 135 articles, from which 1013 indicators were retrieved. Indicators assessing the diagnostic process showed a decreasing trend: from 33 indicators reporting on screening, 30 (91%) signalled a decrease during the pandemic (n = 30 indicators, 91%). A reduction was also observed in the number of diagnostic procedures (n = 64, 58%) and diagnoses (n = 130, 89%). The proportion of diagnoses in the emergency setting and waiting times showed increasing trends (n = 8, 89% and n = 14, 56%, respectively). A decreasing trend in the proportion of earliest stage cancers was reported by 63% of indicators (n = 9), and 70% (n = 43) of indicators showed an increasing trend in the proportion of advanced-stage cancers. Indicators reflecting the treatment process signalled a reduction in the number of procedures: 79%(n = 82) of indicators concerning surgeries, 72%(n = 41) of indicators assessing radiotherapy, and 93%(n = 40) of indicators related to systemic therapies. Modifications in cancer treatment were frequently reported: 64%(n = 195) of indicators revealed changes in treatment. Conclusions This study provides a summary of performance indicators used in the literature to assess the cancer care pathway from January 2020 to June 2020 in OECD countries, and the changes in the quality of care signalled by these indicators. The trends reported inform on potential bottlenecks of the cancer care pathway. Monitoring this information closely could contribute to identifying moments for intervention during crises.

show abstract

Effects of COVID-19 Outbreak on Emergency Surgeries for Occlusive Colorectal Cancers

Cited by 8 publications

References 0 publications

Changes in the quality of cancer care as assessed through performance indicators during the first wave of the COVID-19 pandemic in 2020: a Scoping Review

Changes in the quality of cancer care as assessed through performance indicators during the first wave of the COVID-19 pandemic in 2020: a Scoping Review

The safety of digestive tract cancer surgery during COVID-19: A living systematic review and meta-analysis

Changes in the quality of cancer care as assessed through performance indicators during the first wave of the COVID-19 pandemic in 2020: a scoping review

Contact Info

Product

Resources

About